IART
INTEGRA LIFESCIENCES HOLDINGS CORP
Key Financials
Revenue
$1.6B
↑ 1.5%
Operating Income
$-493370000
↓ 1836.5%
Gross Profit
$851.0M
↑ 252.3%
Net Income
$-516474000
↓ 7337.7%
EPS (Diluted)
$-6.74
↓ 7388.9%
Shareholders' Equity
$1.0B
↓ 32.5%
Total Assets
$3.6B
↓ 10.8%
Total Liabilities
$2.6B
↑ 2.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| S-8 | 5/8/2026 | View on SEC |
| 8-K | 5/8/2026 | View on SEC |
| 10-Q | 5/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IART |
| Company Name | INTEGRA LIFESCIENCES HOLDINGS CORP |
| CIK | 917520 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 6092750500 |